# nintedanib

NDC: 0781-2495
Generic name: nintedanib
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20260402

FDA application: ANDA216915

## Active ingredients

- NINTEDANIB ESYLATE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0781-2495"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0781-2495
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=751c3473-35d6-47d6-b405-af16a989716c